ã©ãã©ããªãŒã»ã³ãŒãã¬ãŒã·ã§ã³ã»ãªãã»ã¢ã¡ãªã«ã»ããŒã«ãã£ã³ã°ã¹ã¯ãç¬ç«ããèšåºæ€æ»äŒç€ŸãšããŠäžçäžã§äºæ¥ãå±éããŠããŸããå瀟ã¯ãLabcorp Diagnostics (Dx) ãš Labcorp Drug Development (DD) ã® 2 ã€ã®ã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸããè¡æ¶²ååŠåæãå°¿æ€æ»ãè¡çæ°ãç²ç¶è
ºæ€æ»ãããããã¹ãããã¢ã°ããã³ A1C ããã³ãã¿ãã³ D 補åãåç«è
ºç¹ç°æåãæ§ææçæ€æ»ãC åèçæ€æ»ã埮çç©å¹é€ããã³åŠçœ®ãã¢ã«ã³ãŒã«ããã³ãã®ä»ã®è¬ç©ä¹±ç𿀿»ãªã©ãããŸããŸãªæ€æ»ãæäŸããŠããŸããå瀟ã¯ãŸããéºäŒåããŒã¹ããã³é£è§£ãªæ€æ»ãããªãå°éæ€æ»ãµãŒãã¹ãæäŸããŠããŸããé«åºŠãªæ€æ»ã¯ãè§£åç
çåŠ/è
«çåŠãå¿è¡ç®¡çŸæ£ãååºã蚺æéºäŒåŠãå
åæ³åŠãææçã女æ§ã®å¥åº·ãè¬çéºäŒåŠã芪åé¢ä¿ããã³ãããŒæ€æ»ãªã©ãç¹å®ã®çŸæ£ã察象ãšããŠããŸãããŸããè·æ¥æ€æ»ãµãŒãã¹ãå»çè¬ç©ã¢ãã¿ãªã³ã°ãµãŒãã¹ãæ
¢æ§çŸæ£ããã°ã©ã ãããã³è
èçµç³äºé²æ€æ»ãæäŸããŠããŸããå瀟ã¯ãæ£è
ãæ€æ»çµæã確èªã§ãããªã³ã©ã€ã³ããã³ã¢ãã€ã«ã¢ããªã±ãŒã·ã§ã³ãæ£è
ã»ã«ããµãŒãã¹ã¢ããªãæäŸããŠããŸãããããŒãžãã±ã¢çµç¹åãã®ãªã³ã©ã€ã³ ã¢ããªã±ãŒã·ã§ã³ãæäŸããŠããŸããåææ®µéã®ç ç©¶ããèšåºéçºãåçšåžå Žãžã®ã¢ã¯ã»ã¹ãŸã§ããšã³ãããŒãšã³ãã®å»è¬åéçºãå»çæ©åšã蚺æéçºãœãªã¥ãŒã·ã§ã³ãæäŸããŠããŸããå瀟ã¯ãããæ£è
ã«å¯Ÿãã粟å¯å»çã®æ Œå·®ã®åœ±é¿ãçè§£ããããã«ãã³ãã¥ãã㣠ã¯ãªãã«ã« ãªã³ã³ããžãŒ ãªãµãŒã ãããã¯ãŒã¯ LLC ãšååå¥çŽãçµãã§ããã»ããGeneCentric Therapeutics, Inc. ãšæŠç¥çææºãçµãã§ããŸãããããŒãžãã±ã¢çµç¹ããã€ãªå»è¬åäŒæ¥ãå»åž«ããã®ä»ã®å»çæäŸè
ãç
é¢ãå»çå¶åºŠãæ¿åºæ©é¢ãéçšäž»ãæ£è
ãæ¶è²»è
ãå¥çŽç ç©¶æ©é¢ã蟲äœç©ä¿è·ããã³ååŠäŒæ¥ãåŠè¡æ©é¢ãç¬ç«èšåºç ç©¶æã«ãµãŒãã¹ãæäŸããŠããŸããå瀟㯠1971 幎ã«èšç«ãããããŒã¹ã«ãã©ã€ãå·ããŒãªã³ãã³ã«æ¬ç€Ÿã眮ããŠããŸãã